Autophagosome degraders: a novel therapeutic strategy with broad application potential in human diseases
Future Medicinal Chemistry · 2026
DOI: 10.1080/17568919.2025.2605014 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Future Medicinal Chemistry, 2026. Verfasst von Wei-Fang Zuo und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Southwestern Chinese Medicine Resources, School of Basic Medical Sciences, School of Pharmacy, Chengdu University of Traditio…. Hauptthemen laut MEDLINE: Autophagosomes, Neurodegenerative Diseases, Neoplasms. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Sichuan Science and Technology Program, Xinglin Scholar Research Promotion Project of Chengdu University of TCM.
Abstract (Originalsprache)
Autophagy-mediated targeted protein degradation, exemplified by technologies such as autophagosome-tethering compounds (ATTECs), AUTOphagy-TArgeting chimeras (AUTOTACs), and autophagy-targeting chimeras (AUTACs), leverages the autophagy-lysosome pathway for the clearance of challenging substrates that often exceed proteasomal capacity. These substrates include large protein aggregates, multi-protein complexes, and even entire organelles. This review synthesizes key advances in the development of autophagy-based degraders since 2022, highlighting their therapeutic potential through exemplar applications. We discuss their utility in oncology, neurodegenerative disorders, and inflammatory/cardiometabolic diseases. These novel modalities have demonstrated potent, selective, and durable substrate elimination in vivo, successfully overcoming resistance mechanisms associated with traditional occupancy-driven inhibition. Finally, we summarize the general workflow for developing autophagy-based degraders, outline the current challenges and future directions in this field, and aim to promote fundamental mechanistic studies and innovative medicinal chemistry research, thereby accelerating the clinical translation of autophagy-targeting degraders for the treatment of various human diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Southwestern Chinese Medicine Resources, School of Basic Medical Sciences, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
ORCID-Profile: Bo Han
Förderung
- National Natural Science Foundation of China
- Sichuan Science and Technology Program
- Xinglin Scholar Research Promotion Project of Chengdu University of TCM
Zitieren
APA
Zuo, W. F., Huang, X., Peng, C., Han, B., & Zhao, Q. (2026). Autophagosome degraders: a novel therapeutic strategy with broad application potential in human diseases. Future Medicinal Chemistry. https://doi.org/10.1080/17568919.2025.2605014
Vancouver
Zuo WF, Huang X, Peng C, Han B, Zhao Q. Autophagosome degraders: a novel therapeutic strategy with broad application potential in human diseases. Future Medicinal Chemistry. 2026. doi:10.1080/17568919.2025.2605014
BibTeX
@article{Zuo2026,
author = {Zuo, Wei-Fang and Huang, Xinyi and Peng, Cheng and Han, Bo and Zhao, Qian},
title = {Autophagosome degraders: a novel therapeutic strategy with broad application potential in human diseases},
journal = {Future Medicinal Chemistry},
year = {2026},
doi = {10.1080/17568919.2025.2605014}
}
EUVIMED